Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 219.00
Bid: 220.00
Ask: 221.00
Change: 4.00 (1.86%)
Spread: 1.00 (0.455%)
Open: 214.00
High: 220.50
Low: 214.00
Prev. Close: 215.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

2 Nov 2018 07:00

RNS Number : 1541G
TP ICAP PLC
02 November 2018
 

02 November 2018

TP ICAP PLC

Trading Update

TP ICAP plc (the "Company") is today issuing a trading update for the four months ended 31 October 2018. 

Revenue in the four months to October 2018 of £568m was 1% higher than the £562m revenue for the same period last year and 1% higher at constant exchange rates. Year to date (January to October) revenue of £1,478m was 1% lower than the £1,487m revenue for the same period last year and 3% higher at constant exchange rates.

In the four months to October revenue growth reflects mixed market conditions during the period. Global Broking revenue for the period was in line with the prior year and 3% higher year to date on a constant currency basis with both Rates and Equities performing well. Energy & Commodities revenue was in line with the prior year period, and 2% lower year to date on a constant currency basis, with market conditions remaining challenging across the majority of our Energy & Commodities products.

Our Data & Analytics business saw strong revenue growth in the period of 11%, and 7% year to date on a constant currency basis, as the business has benefitted from strategic changes implemented by its new management. Institutional Services revenue grew by 12% in the period and 7% year to date on a constant currency basis with COEX in particular seeing significant growth.

We expect the outcome for the full year to be in line with our guidance.

The Company will report the preliminary results for the 2018 financial year on 19 March 2019.

Nicolas Breteau, Chief Executive, TP ICAP plc, said: "Today's trading update demonstrates that TP ICAP is well placed to grow in mixed market conditions, characterised by periodic volatility that we saw in October following the US Federal Reserve's rates decision.

This underlines our firmly-held belief that investing in growth areas such as Data & Analytics will benefit TP ICAP over the longer-term as we develop solid and scalable revenues across our global businesses.

I am also pleased to announce the acquisition of Axiom Commodity Group, an energy and commodities broker based in the US. The purchase of Axiom, which has 22 brokers and specialises in crude oil, refined oil products, ethanol and physical grains, continues the expansion of our Energy & Commodities division and reinforces our existing presence in Houston, Texas."

For further information:

Analysts and Investors

Sam Dobbyn

Group Head of Financial Planning and Analysis

sam.dobbyn@tpicap.com

+44 (0) 20 7200 7147

 

Media

Rebecca Shelley

Group Corporate Affairs Director

rebecca.shelley@tpicap.com

+44 (0) 20 7200 7750

 

Jamie Dunkley 

Group Media Relations Director

jamie.dunkley@tpicap.com

+44 (0) 20 7200 7524

 

Notes to Editors:

 

About TP ICAP

 

TP ICAP Group manages a portfolio of businesses, providing intermediary services, contextual insights and intelligence, trade execution solutions and data and analytics. 

 

For further information on TP ICAP please visit www.tpicap.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUGGPWGUPRUQP
Date   Source Headline
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.